Skip to content

Curcumin With and Without Strengthening Exercises in Rheumatoid Arthritis

Evaluation of Therapeutic Potential of Curcumin With and Without Strengthening Exercises in improving Rheumatoid Arthritis

Status
Active, not recruiting
Phases
Phase 3
Study type
Observational
Source
IRCT
Registry ID
IRCT20220401054388N1
Enrollment
100
Registered
2022-04-11
Start date
2021-06-18
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis. Rheumatoid arthritis with rheumatoid factor

Interventions

Intervention 1: Intervention group:Treatment group A was treated with Curcumin and strengthening exercises, and control group B was treated with Curcumin only. Curcumin was purcha
each session lasted for 45 minutes. There were total 18 sessions. And treatment duration was 6 weeks. And 180 mg/day orally Curcumin was given. Intervention 2: Control group: control

Sponsors

Ali –Ul- Murtaza Department of Rehabilitation Science, MIMAS
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients of all ages Diagnosed RA Both gender Patients with swelling in joints and pain

Exclusion criteria

Exclusion criteria: Vascular neoplasia Fibromyalgia Radiculopathy Neuropathy, Tumor, joint fractures, and vestibular problems

Design outcomes

Primary

MeasureTime frame
Pain,stiffness,Physical activities and joint deformity. Timepoint: 6 weeks. Method of measurement: WOMAC and NPRS scale+ Radiographica; findings.

Secondary

MeasureTime frame
Increase independency+ decrease in inflammatory biomarkers+ Immunity booster. Timepoint: 6 weeks. Method of measurement: WOMAC and NPRS scale+lab investigations.

Countries

Pakistan

Contacts

Public ContactImran Ahmad Khan

Ali –Ul- Murtaza Department of Rehabilitation Science,MIMAS

imranahmadkhandurrani@gmail.com+92 312 6827130

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026